Anxiety and Related Sleep Disorders - APAC

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$1.85bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.60%, resulting in a market volume of US$1.91bn by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$11.36 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in APAC is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this growth.Customer preferences in the APAC region are playing a key role in the development of the Anxiety and Related Sleep Disorders market. Increasing awareness about mental health and the importance of sleep is leading to a higher demand for products and services that address anxiety and sleep disorders. Customers are seeking out solutions that can help them manage stress, improve sleep quality, and enhance their overall well-being.Several trends are driving the growth of the Anxiety and Related Sleep Disorders market in APAC. One major trend is the increasing adoption of digital health solutions. Mobile apps, wearable devices, and online platforms are becoming popular tools for managing anxiety and sleep disorders. These digital solutions provide convenience and accessibility, allowing individuals to track their symptoms, access resources, and receive personalized recommendations.Another trend is the rise of alternative therapies and natural remedies. Traditional practices such as acupuncture, herbal medicine, and meditation are gaining popularity as people seek holistic approaches to managing anxiety and sleep disorders. This trend is driven by a growing interest in natural and non-pharmaceutical solutions, as well as a desire for personalized and individualized care.Local special circumstances in APAC also contribute to the development of the Anxiety and Related Sleep Disorders market. In some countries, there is a high prevalence of anxiety and sleep disorders due to factors such as work-related stress, urbanization, and lifestyle changes. These local circumstances create a demand for products and services that can address these specific needs.Underlying macroeconomic factors are also playing a role in the growth of the Anxiety and Related Sleep Disorders market in APAC. Economic growth and rising disposable incomes in many countries are enabling individuals to prioritize their mental health and well-being. As people become more financially capable, they are willing to invest in products and services that can help them manage anxiety and sleep disorders.In conclusion, the Anxiety and Related Sleep Disorders market in APAC is growing and developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing awareness about mental health, the adoption of digital health solutions, the rise of alternative therapies, local circumstances, and economic growth are all contributing to this growth. As the market continues to evolve, it is likely to see further advancements in products and services that cater to the specific needs of individuals in the APAC region.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.